Work

Nivolumab (Anti-PD1) Therapy for Relapsed/ Refractory Primary Central Nervous System Lymphoma and Primary Testicular Lymphoma

Year: 2016

Type: article

Source: Blood

DOI: 10.1182/blood.v128.22.930.930

Authors: Lakshmi Nayak, Fabio Iwamoto, Ann S. LaCasce, Srinivasan Mukundan, Margaretha G M Roemer, Bjoern Chapuy, Philippe Armand, Scott J. Rodig, Margaret A. Shipp

Institutions: Dana-Farber Cancer Institute, Columbia University, Brigham and Women's Hospital

Language: English

Topic: CNS Lymphoma Diagnosis and Treatment

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2593935970

FWCI: 0.862

Cites:

Cited by: 4

Related to: 10